Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Jaundice

The prevalence of G6PD deficiency among jaundiced neonates in the absence of any precipitating factor. The association between neonatal jaundice and G6PD activity level . The lines and the efficacy of treatment of neonatal jaundice in G6PD deficient neonates. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common inherited disorders of mankind: more than 400 million people are affected worldwide (Kaplan M & Hammerman C ،2002). Its incidence varies from, 3% in the United States and Europe to 25% in some parts of Africa and the Middle East. Within any given area, the incidence may vary between population subgroups (Mesner O et al.,2004). Neonatal jaundice is one of the manifestations of this condition and it can be severe enough to cause kernicterus, resulting in death or permanent